Investor List:

Top Medical Devices Series B Investors in New York City (57)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Thilo Semmelbauer, Managing Director at Insight Partners
Thilo Semmelbauer
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Steve Kraus, Partner at Bessemer Venture Partners
Steve Kraus
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in Boston / New England, Investors in New York (NY), Investors in Boston (MA)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Alex Glassman, Vice President at Insight Partners
Alex Glassman
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in SaaS (Series B), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in SaaS (Seed), Investors in Medical Devices (Series A), Investors in SaaS (Series A), Investors in Medical Devices (Series B), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in SaaS (Seed)
Photo of Connor Guess, Vice President at Insight Partners
Connor Guess
Insight Partners·Vice President
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Carl  Gordon, Managing Partner at OrbiMed
Carl Gordon
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Diyong Xu, Principal at OrbiMed
Diyong Xu
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Washington, D.C. (Other Lists), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
Photo of William Lane, Managing Partner at Ethos Family Office
William Lane
Ethos Family Office·Managing Partner
Sweet spot: $750K
Range: $50K - $15.0M
Investors in Philadelphia (PA)
Investors in AgTech (Series B), Investors in Material Science (Seed), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Medical Devices (Seed), Investors in Semiconductors (Seed), Investors in Food and Beverage (Series B), Investors in Medical Devices (Series A), Investors in Semiconductors (Series B), Investors in New York City (Other Lists), Investors in Medical Devices (Series B), Investors in Food and Beverage (Seed), Investors in Medical Devices (Seed), Investors in Real Estate/PropTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Medical Devices (Series A), Investors in Real Estate/PropTech (Pre-seed), Investors in Real Estate/PropTech (Series A), Investors in AgTech (Seed), Investors in AgTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in Material Science (Series B), Investors in Material Science (Series A), Investors in Real Estate/PropTech (Series B), Investors in Semiconductors (Series A), Investors in AI (Series B), Investors in Diverse Investors (Other Lists), Investors in AI (Seed), Investors in Investors who were founders (Other Lists), Investors in AI (Series A), Investors in FinTech (Series B), Investors in AI (Series A), Investors in Future of Work (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in Material Science (Seed), Investors in Semiconductors (Seed), Investors in Medical Devices (Pre-seed), Investors in AI (Seed), Investors in FinTech (Series A), Investors in Food and Beverage (Series B), Investors in Food and Beverage (Series A), Investors in Food and Beverage (Pre-seed), Investors in FinTech (Seed), Investors in Future of Work (Seed), Investors in AgTech (Series B), Investors in FinTech (Series B), Investors in Material Science (Series A), Investors in Real Estate/PropTech (Series A), Investors in Semiconductors (Series A), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Material Science (Series B), Investors in Future of Work (Series A), Investors in Real Estate/PropTech (Series B), Investors in Semiconductors (Series B), Investors in AI (Pre-seed), Investors in Future of Work (Pre-seed), Investors in AgTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Semiconductors (Pre-seed), Investors in AgTech (Pre-seed), Investors in AI (Pre-seed), Investors in FinTech (Pre-seed), Investors in Future of Work (Pre-seed), Investors in Food and Beverage (Series A), Investors in Medical Devices (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Semiconductors (Pre-seed), Investors in FinTech (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Material Science (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed)